Ethics and patentability in biotechnology.
The systems of patent rights in force in Europe today, both at the level of national law and on the regional level, contain general clauses prohibiting the patenting of inventions whose publication and exploitation would be contrary to "ordre public" or morality. Recent years have brought frequent discussion about limiting the possibility of patent protection for biotechnological inventions for ethical reasons. This is undoubtedly a result of the dynamic development in this field in the last several years. Human genome sequencing, the first successful cloning of mammals, and the progress in human stem cell research present humanity with many new questions of an ethical nature. Directive 98/44 of the European Parliament and of the Council of July 6, 1998, on the Legal Protection of Biotechnological Inventions created a new basis for patent protection in this field of technology. Based on the European experience to now, however, it must be said that patent law is not the right place to legislate the consequences of the morality of an invention.
Witek
Rafał
R
Witek, Twardowska, Sniezko, Patent Attorneys, Wrocław, Poland. witek@wtspatent.pl
D001675:Bioethics; D001709:Biotechnology / Q000941:ethics* / Q000331:legislation & jurisprudence; D005060:Europe; D010330:Patents as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence